Newsletter | February 21, 2025

02.21.25 -- The FDA's View Of AI In Clinical Trials Is Limited

SPONSOR

What’s the real impact of the "one-and-done PI" in clinical trials? Some say it’s a major issue, while others question if it’s a concern at all. Clinical Leader Live’s expert panel—backed by research—dives into the data, debate, and potential solutions. Join this free digital event!

CLINICAL DATA MANAGEMENT & ANALYTICS

The FDA's View Of AI In Clinical Trials Is Limited

Video | By Clinical Leader Live

Tala Fakhouri explains that there could be so many more applications of AI in clinical development than what the FDA sees in regulatory submissions.

Understanding Phase 4 Trials: Post-Marketing Insight

Article | Castor

Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

Transforming Clinical Trial Disclosure With AI

Article | Citeline

Unlock the full potential of AI to address sponsor challenges including regulatory complexity, clinical trial disclosure requirements, and growing demands for transparency.

Design and Execute Faster Trials with AI-Powered Insights

Brochure | Medidata AI

Explore how Intelligent Trials leverages the industry’s largest clinical dataset to accelerate enrollment, improve diversity, and provide real-time insights, ensuring efficient, data-driven trial success.

An End-To-End Clinical Data Science Platform

Brochure | Revvity Signals Software, Inc.

Discover how using Signals Clinical™, a SaaS clinical data science solution, can help you streamline clinical data workflows and reduce the time spent on manual analytics data preparation tasks.

Unlock Next-Generation Prescription Insights With A Comprehensive Solution

Brochure | Cencora PharmaLex

Understanding patient treatment journeys is paramount. PES offers a comprehensive solution, providing a holistic view of how patients navigate their treatment pathways.

TRIAL MONITORING

How Changes To The Declaration Of Helsinki Impact Clinical Trials

Guest Column | By Jessica Cordes, Clinical Excellence GmbH

Consultant Jessica Cordes breaks down the latest version of the Declaration of Helsinki and how it builds upon the previous version from 2013.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: